One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Epidemiologic Methods to Advance Our Understanding of Ovarian Cancer Risk.
Harris, Holly R. ScD, MPH 1,2,; Davis, Colette P. PhD, MSPH, MS 3; Terry, Kathryn L. ScD 4,5,6,
doi : 10.1200/JCO.24.00602
Volume 42(22) pgs. 2619-2725 August 1, 2024
Taletrectinib: TRUST in the Continued Evolution of Treatments for ROS1 Fusion-Positive Lung Cancer.
Waliany, Sarah MD, MS 1,; Lin, Jessica J. MD 1,,
doi : 10.1200/JCO.24.01062
Duress and Distress Versus a Neurocognitive Mess: The Challenges of Procedural Sedation in Pediatric B-ALL.
Turcotte, Lucie M. MD, MPH, MS 1,; Neglia, Joseph P. MD, MPH 1
doi : 10.1200/JCO.24.00472
Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer.
Rios-Hoyo, Alejandro MD 1,; Cobain, Erin MD 2,; Huppert, Laura A. MD 3,; Beitsch, Peter D. MD 4,; Buchholz, Thomas A. MD 5,; Esserman, Laura MD 3,; van 't Veer, Laura J. PhD 3,; Rugo, Hope S. MD 3,; Pusztai, Lajos MD, DPhil 1,,
doi : 10.1200/JCO.23.02614
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study.
Antoniotti, Carlotta MD, PhD 1,2,; Rossini, Daniele MD, PhD 2,3,; Pietrantonio, Filippo MD 4,; Salvatore, Lisa MD, PhD 5,6,; Lonardi, Sara MD 7,; Tamberi, Stefano MD, PhD 8; Marmorino, Federica MD, PhD 1,2; Moretto, Roberto MD 1; Prisciandaro, Michele MD 4; Tamburini, Emiliano MD 9,; Tortora, Giampaolo MD, PhD 5,6,; Passardi, Alessandro MD 10; Bergamo, Francesca MD 7,; Raimondi, Alessandra MD 4,; Ritorto, Giuliana MD 11; Borelli, Beatrice MD, PhD 1; Conca, Veronica MD 1,2; Ugolini, Clara MD, PhD 12; Aprile, Giuseppe MD 13,; Antonuzzo, Lorenzo MD 14,15,; Gelsomino, Fabio MD 16,; Martinelli, Erika MD, PhD 17,; Pella, Nicoletta MD 18; Masi, Gianluca MD 1,2,; Boni, Luca MD 19,; Galon, Jerome PhD 20,21,22,; Cremolini, Chiara MD, PhD 1,2,,
doi : 10.1200/JCO.23.02728
Intimate Care Products and Incidence of Hormone-Related Cancers: A Quantitative Bias Analysis.
O'Brien, Katie M. PhD, MSPH 1,; Wentzensen, Nicolas MD, PhD, MS 2; Ogunsina, Kemi MD, PhD, MPH 1; Weinberg, Clarice R. PhD 3; D'Aloisio, Aimee A. PhD, MS 4; Edwards, Jessie K. PhD, MSPH 5; Sandler, Dale P. PhD 1
doi : 10.1200/JCO.23.02037
Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I Study.
Li, Wei MD 1; Xiong, Anwen MD 1; Yang, Nong MD 2; Fan, Huijie MD 3; Yu, Qitao MD 4; Zhao, Yanqiu MD 5; Wang, Yongsheng MD 6; Meng, Xue MD 7; Wu, Jingxun MD 8; Wang, Ziping MD 9; Liu, Yunpeng MD 10; Wang, Xicheng MD 11; Qin, Xintian MD 12; Lu, Kaihua MD 13; Zhuang, Wu MD 14; Ren, Yizhong PhD 15,; Zhang, Xianyu MS 15; Yan, Bing MD, MBA 15,; Lovly, Christine M. MD, PhD 16,; Zhou, Caicun MD, PhD 1,,
doi : 10.1200/JCO.24.00731
Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL: A Children's Oncology Group Study.
Alexander, Sarah MD 1,; Kairalla, John A. PhD 2,; Gupta, Sumit MD, PhD 1,; Hibbitts, Emily PhD 2,; Weisman, Hannah BSc 3,; Anghelescu, Doralina MD 4; Winick, Naomi J. MD 5; Krull, Kevin R. PhD 6,; Salzer, Wanda L. MD 7; Burke, Michael J. MD 8,; Gore, Lia MD 9,; Devidas, Meenakshi PhD 10,; Embry, Leanne PhD 11; Raetz, Elizabeth A. MD 12,; Hunger, Stephen P. MD 13,; Loh, Mignon L. MD 14; Hardy, Kristina K. PhD 3
doi : 10.1200/JCO.23.01989
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5.
Cortes, Javier MD, PhD 1,2,3,; Hurvitz, Sara A. MD 4,; O'Shaughnessy, Joyce MD 5,; Delaloge, Suzette MD 6,; Iwata, Hiroji MD, PhD 7,; Rugo, Hope S. MD 8,; Neven, Patrick MD, PhD 9,; Kanagavel, Dheepak MD, PhD 10,; Cohen, Patrick MD 10,; Paux, Gautier MSc 11,; Cartot-Cotton, Sylvaine PharmD 12,; Stefanova-Urena, Maya MD 13; Deyme, Laure PhD 14,; Aouni, Jihane PhD 12,15; Sebastien, Bernard PhD 12,; Bardia, Aditya MD, MPH 16,,
doi : 10.1200/JCO.23.02036
Plasma Kidney Injury Molecule-1 for Preoperative Prediction of Renal Cell Carcinoma Versus Benign Renal Masses, and Association With Clinical Outcomes.
Xu, Wenxin MD 1,,; Gaborieau, Valerie DUT 2; Niman, Samuel M. MS 1; Mukeria, Anush MD, DSc 3; Liu, Xiaowen PhD 4; Maremanda, Krishna P. PhD 5; Takakura, Ayumi PhD 5; Zaridze, David MD, DSc 3; Freedman, Matthew L. MD 1,; Xie, Wanling MS 1,; McDermott, David F. MD 4,; Choueiri, Toni K. MD 1,; Catalano, Paul J. ScD 1,; Sabbisetti, Venkata PhD 5,; Bonventre, Joseph V. MD, PhD 5,; Pierorazio, Phillip M. MD 6,; Singla, Nirmish MD, MSc 7; Brennan, Paul PhD 2; Bhatt, Rupal S. MD, PhD 4,
doi : 10.1200/JCO.23.00699
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma.
Bumma, Naresh MD 1,; Richter, Joshua MD 2,; Jagannath, Sundar MD 2,; Lee, Hans C. MD 3,; Hoffman, James E. MD 4,; Suvannasankha, Attaya MD 5,; Zonder, Jeffrey A. MD 6,; Shah, Mansi R. MD 7,; Lentzsch, Suzanne MD, PhD 8,; Baz, Rachid MD 9,; Maly, Joseph J. MD 10; Namburi, Swathi MD 11,; Pianko, Matthew J. MD 12,; Ye, Jing Christine MD, MS 12,; Wu, Ka Lung MD, PhD 13,; Silbermann, Rebecca MD 14,; Min, Chang-Ki MD 15; Vekemans, Marie-Christiane MD 16,; Munder, Markus MD 17,; Byun, Ja Min MD 18; Martinez-Lopez, Joaquin MD 19,; Cassady, Kaniel PhD 20,; DeVeaux, Michelle PhD 20,; Chokshi, Dhruti BS 20,; Boyapati, Anita PhD 20,; Hazra, Anasuya PhD 20,; Yancopoulos, George D. MD, PhD 20,; Sirulnik, L. Andres MD, PhD 20,; Rodriguez Lorenc, Karen MD 20,; Kroog, Glenn S. MD 20,; Houvras, Yariv MD, PhD 20,; Dhodapkar, Madhav V. MD 21,,
doi : 10.1200/JCO.24.01008
FASTOCH: Feasibility of Electronic Patient-Reported Outcomes in Older Patients With Cancer-A Multicenter Prospective Study.
Cancel, Mathilde MD, PhD 1,,; Sauger, Carine MA 2; Biogeau, Julie MD 3; Dardaine-Giraud, Veronique MD 3; Lecomte, Thierry MD, PhD 4,; Solub, David MD 5,; Combe, Pierre MD 6,; Wilmet, Remy MD 7; Aubard, Eugenie MA 8; Deloigne, Amandine BSC 9; Hebrard, Philippe Ing 10,; Dorval, Etienne MD, PhD 2
doi : 10.1200/JCO.23.02150
Vulvar Squamous Cell Carcinoma Guidelines May Benefit From Consideration of Tissue-Sparing Techniques as Treatment Options.
Fellon, Corey M. BS; Elsensohn, Ashley N. MD, MPH; Kraus, Christina N. MD; Virgen, Cesar A. MD, PhD
doi : 10.1200/JCO.24.00572
Reply to C.M. Fellon et al.
Chargari, Cyrus MD, PhD; Maingon, Philippe MD, PhD
doi : 10.1200/JCO.24.00628
Erratum: Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04).
doi : 10.1200/JCO.24.01092
